- Home
- JG vs IGC Comparison
JG vs IGC Comparison
Compare JG & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JG
- IGC
- Stock Information
- Founded
- JG 2012
- IGC 2005
- Country
- JG China
- IGC United States
- Employees
- JG N/A
- IGC N/A
- Industry
- JG Computer Software: Programming Data Processing
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- JG Technology
- IGC Health Care
- Exchange
- JG Nasdaq
- IGC Nasdaq
- Market Cap
- JG 48.4M
- IGC 39.8M
- IPO Year
- JG 2018
- IGC N/A
- Fundamental
- Price
- JG N/A
- IGC N/A
- Analyst Decision
- JG
- IGC Strong Buy
- Analyst Count
- JG 0
- IGC 2
- Target Price
- JG N/A
- IGC $4.00
- AVG Volume (30 Days)
- JG 10.4K
- IGC 727.1K
- Earning Date
- JG 11-13-2025
- IGC 11-11-2025
- Dividend Yield
- JG N/A
- IGC N/A
- EPS Growth
- JG N/A
- IGC N/A
- EPS
- JG N/A
- IGC N/A
- Revenue
- JG $48,999,972.00
- IGC $1,327,000.00
- Revenue This Year
- JG $10.90
- IGC $3.54
- Revenue Next Year
- JG N/A
- IGC $15.12
- P/E Ratio
- JG N/A
- IGC N/A
- Revenue Growth
- JG 18.82
- IGC 24.95
- 52 Week Low
- JG $4.25
- IGC $0.25
- 52 Week High
- JG $20.94
- IGC $0.50
- Technical
- Relative Strength Index (RSI)
- JG 43.58
- IGC 53.83
- Support Level
- JG $8.00
- IGC $0.38
- Resistance Level
- JG $8.79
- IGC $0.44
- Average True Range (ATR)
- JG 0.32
- IGC 0.02
- MACD
- JG 0.04
- IGC -0.00
- Stochastic Oscillator
- JG 67.42
- IGC 59.50
About JG Aurora Mobile Limited
Aurora Mobile Ltd provides stable, and accurate developer services for educational and medical products. It is focused on providing companies with stable and efficient push notification services. It provides a comprehensive suite of services to mobile app developers in mainland China. Through its developer services, it gains access to, aggregate, cleanse, structure and encrypt vast amounts of real-time and anonymous device-level mobile behavioral data. It offers data services such as iAPP which helps the investors to analyze opportunities in the sector, Anti-fraud helps to identify fraud risks, iAudience, iZone and other related services. The company operates and generates its revenue from the People's Republic of China.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.